News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Climb Bio, Inc. - Common Stock
(NQ:
CLYM
)
4.250
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Climb Bio, Inc. - Common Stock
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 06, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Present at Upcoming Investor Conferences
November 03, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy
October 21, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
October 17, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer
October 01, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN
September 29, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
September 04, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences
August 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Present at Upcoming September 2025 Investor Conferences
August 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 12, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
June 18, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
May 14, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
April 01, 2025
Appointments Include Industry Veterans Kim Cobleigh Drapkin, CPA, and Bo Cumbo as Independent Directors
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference
March 27, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates
March 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Present at Upcoming Investor Conferences
February 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
February 24, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 04, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy
January 09, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to be Added to the Nasdaq Biotechnology Index
December 19, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
November 12, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
November 11, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Present at Upcoming Investor Conferences
October 31, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
October 15, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
October 11, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
October 04, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Host Virtual Investor Event on October 15, 2024
October 03, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.